Nanocarriers for siRNA delivery to overcome cancer multidrug resistance

被引:0
|
作者
MENG QingShuo [1 ]
YIN Qi [1 ]
LI YaPing [1 ]
机构
[1] Center of Pharmaceutics,Shanghai Institute of Materia Medica,Chinese Academy of Sciences
基金
中国国家自然科学基金;
关键词
cationic polymers; inorganic carriers; liposomes; multidrug resistance; nanocarriers; siRNA delivery;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
Multidrug resistance(MDR)is an extremely complexed phenomenon in tumor chemotherapy and is one of the major obstacles for successful treatment.Discovery of RNA interference(RNAi)offers a new strategy with great potential to reverse MDR.Specific genes,which contribute to the emerging of MDR,can be silenced by RNAi.However,many natural barriers have to be overcome for efficient and safe delivery of siRNA.In recent years,the various kinds of nanocarriers,such as liposomes,cationic polymers,and inorganic materials,have been developed to deliver siRNA and show good results in reversing MDR.This review mainly summarizes the barriers in siRNA delivery and recent progress in designing nanotechnology-based siRNA delivery systems to overcome tumor MDR.
引用
收藏
页码:4021 / 4030
页数:10
相关论文
共 50 条
  • [41] Multi-functional microemulsion delivery system to overcome tumor multidrug resistance
    Qu, Ding
    Zhou, Jing
    Liu, Cong-Yan
    Chen, Yan
    JOURNAL OF CONTROLLED RELEASE, 2015, 213 : E27 - E27
  • [42] Multifunctional Nanoparticles as Nanocarrier for Vincristine Sulfate Delivery To Overcome Tumor Multidrug Resistance
    Wang, Yuan
    Dou, Limei
    He, Huijuan
    Zhang, Yi
    Shen, Qi
    MOLECULAR PHARMACEUTICS, 2014, 11 (03) : 885 - 894
  • [43] The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance
    Mayer, LD
    Shabbits, JA
    CANCER AND METASTASIS REVIEWS, 2001, 20 (1-2) : 87 - 93
  • [44] The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance
    Lawrence D. Mayer
    Jennifer A. Shabbits
    Cancer and Metastasis Reviews, 2001, 20 : 87 - 93
  • [45] One-Step Self-Assembling Nanomicelles for Pirarubicin Delivery To Overcome Multidrug Resistance in Breast Cancer
    Li, Yanping
    Li, Rui
    Liu, Qinhui
    Li, Wenyao
    Zhang, Ting
    Zou, Min
    Li, Hong
    Wu, Tong
    Cheng, Shihai
    Su, Zhiguang
    Zhang, Zhirong
    He, Jinhan
    MOLECULAR PHARMACEUTICS, 2016, 13 (11) : 3934 - 3944
  • [46] Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer
    Cheng, Xu
    Li, Dapeng
    Sun, Min
    He, Le
    Zheng, Yan
    Wang, Xin
    Tang, Rupei
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 181 : 185 - 197
  • [47] Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery
    Wang, Liucan
    Guan, Haidi
    Wang, Zhenqiang
    Xing, Yuxin
    Zhang, Jixi
    Cai, Kaiyong
    MOLECULAR PHARMACEUTICS, 2018, 15 (07) : 2503 - 2512
  • [48] Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells
    Pan, Yuanwei
    Zhou, Suqiong
    Li, Yan
    Parshad, Badri
    Li, Wenzhong
    Haag, Rainer
    JOURNAL OF CONTROLLED RELEASE, 2021, 330 : 1106 - 1117
  • [49] Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance
    Chu, Siwei
    Stochaj, Ursula
    CANCER DRUG RESISTANCE, 2020, 3 (03) : 302 - 333
  • [50] Light-activated mesoporous nanocarriers to overcome drug resistance of cancer cells
    Wang, Liming
    Chen, Chunying
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 519 - 519